ºÚÁϳԹÏ×ÊÔ´

• New paper: Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy
• Molecular Mimicry: How EBV-Triggered T Cells May Attack the Brain in MS

• Advancing Multiple Sclerosis Research: Highlights from the Neuro-SysMed Symposium 2025
• EBV-MS Consortium Showcases Cutting-Edge Research on Epstein-Barr Virus and Multiple Sclerosis at ECTRIMS 2025
• Breaking Ground on EBV and MS: Highlights from ECTRIMS 2025 Educational Session
• Meet Our new EBV-MS Partner: The Cyprus Institute of Neurology and Genetics (CING)
• Meeting with the Scientific Advisory Board of the EBV-MS Project
• On the role of EBV in MS - Educational Session at ECTRIMS 2025
• Epstein-Barr Virus and Its Role in Multiple Sclerosis: A Growing Area of Research

• Research Data Management in EBV-MS

   

• The EBV-MS Annual Consortium Meeting 2024: Reflecting on Progress
• ECTRIMS 2024
• Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design

• How Current Research Shapes the Future of MS Care: A Recap of Our Successful Symposium

   

SVT Februar 2026

Dagens Medicin, Januar 2026

For 30 år siden fantes ingen behandling for sykdommen Sara Louise fikk som 17-åring - _{^{Feb 2025}}

Nytt forskningsprosjekt om kyssesykevirus og MS - _{^{Aug 2025}}

Investigating the Cause of Multiple Sclerosis - ft. Dr. Marianna Cortese - _{^{Feb 2025}}

EBV-MS: Unveiling the relationship between Epstein-Barr virus and multiple sclerosis - _{^{April 2025}}

The new Honorary Doctor hopes to create a vaccine against MS - _{^{Aug 2025}}

How Does EBV Cause MS -- ^{Nov 2025}

Studie: Oppsiktsvekkende om MS-medisin - _{^{Jan 2025}}

Kan hiv-medisin hjelpe mot MS? - _{^{Feb 2024}}

MS i Norge - Sykdommen, Ã¥rsakene og dagens og fremtidens behandling - _²⁰²⁴

Gir nytt håp til MS-syke - _{^{April 2024}}

MS: Et av verdens vanligste virus kan gi svar på gåten bak den nevrologiske sykdommen - _{^{March 2024}}

Kan HIV-medisin virke på MS-pasienter? Norske forskere vil finne det ut - _{^{Oct 2024}}

Case Study Reports Positive Impact of Antiviral Therapy Tenofovir in MS, Warranting Further Research - _{^{Feb 2024}}

Scientists want to tackle multiple sclerosis by treating the kissing virus - _{^{Feb 2024}}

5 quick questions about Epstein-Barr-virus and Multiple Sclerosis - _{^{May 2024}}

Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in people with MS? - _{^{June 2024}}

Risikoen for å få MS økte med 32 ganger etter en EBV-infeksjon - Aug 2023

Leder internasjonalt forskningsprosjekt: – Vi er nærmere en løsning på MS-gåten enn noen gang - _{^{Sept 2023}}

Norske forskere leder EU-prosjekt om MS og kyssesykevirus - Sept 2023

Fantastisk forskningsmiddel-dryss over MS-feltet - _{^{Des 2023}}

Trekker frem en nedtur og to oppturer på MS-feltet i 2023 - _{^{Des 2023}}

Targeting Epstein-Barr virus to treat and prevent MS - _{^{Sept 2023}}

Olivia G. Thomas, Urszula Rykaczewska, Marina Galesic et al (Jan 2026). Cell 189, 585-602 

Mechelli R, Umeton R, Bellucci G, et al. (2025). . Proceedings of the National Academy of Sciences of the United States of America, 122(14), e2418783122.